Visceral obesity and the risk of Barrett's esophagus in Japanese patients with non-alcoholic fatty liver disease
Authors:
- Tomoyuki AkiyamaTATomoyuki Akiyama
- Masato YonedaMYMasato Yoneda
- Masahiko InamoriMIMasahiko Inamori
- Hiroshi IidaHIHiroshi Iida
- Hiroki EndoHEHiroki Endo
- Kunihiro HosonoKHKunihiro Hosono
- Kyoko YonedaKYKyoko Yoneda
- Koji FujitaKFKoji Fujita
- Tomoko KoideTKTomoko Koide
- Chikako TokoroCTChikako Tokoro
- Hirokazu TakahashiHTHirokazu Takahashi
- Ayumu GotoAGAyumu Goto
Open Access
- 21 July 2009
- journal article
- research article
- Published by Springer Nature in BMC Gastroenterology
- Vol. 9 (1) , 56
Abstract
Background: The association between obesity and the risk of Barrett's esophagus (BE) is unclear. Furthermore, the association between visceral obesity and the risk of BE is entirely unknown. Methods: We conducted a retrospective study in 163 patients with non-alcoholic fatty liver disease (NAFLD) who underwent both endoscopy and abdominal CT at an interval of less than a year at our institution. BE was endoscopically diagnosed based on the Prague C & M Criteria. The surface areas of visceral adipose tissue (VAT) and subcutaneous adipose tissue (SAT) were calculated from CT images at the level of the umbilicus. The correlations between the BMI, VAT, and SAT and the risk of BE were examined by univariate and multivariate analyses. Results: Sixty-nine of the 163 study participants (42.3%) were diagnosed to have endoscopic BE, which was classified as short-segment BE (SSBE) in almost all of the cases. There were no significant differences in the age or gender distribution between the groups with and without BE. According to the results of the univariate analysis, VAT was significantly associated with the risk of BE; the BMI tended to be higher in the group with BE than in the group without BE, but this relation did not reach statistical significance. VAT was independently associated with the risk of BE even after adjustment for the BMI. Conclusion: In Japanese patients with NAFLD, obesity tended to be associated with the risk of BE, and this risk appeared to be mediated for the most part by abdominal visceral adiposity.Keywords
This publication has 41 references indexed in Scilit:
- Leptin and the risk of Barrett's oesophagusGut, 2007
- Does body mass index differ between patients with Barrett’s oesophagus and patients with chronic gastro‐oesophageal reflux disease?Alimentary Pharmacology & Therapeutics, 2007
- Obesity increases oesophageal acid exposureGut, 2006
- Systematic review: adipose tissue, obesity and gastrointestinal diseasesAlimentary Pharmacology & Therapeutics, 2006
- Prevalence of Overweight and Obesity in the United States, 1999-2004JAMA, 2006
- Adiponectin and cancer: a systematic reviewBritish Journal of Cancer, 2006
- The association of body mass index with Barrett's oesophagusAlimentary Pharmacology & Therapeutics, 2005
- Relationship between body mass index, diet, exercise and gastro‐oesophageal reflux symptoms in a communityAlimentary Pharmacology & Therapeutics, 2004
- Overweight, obesity and cancer: epidemiological evidence and proposed mechanismsNature Reviews Cancer, 2004
- Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. AdultsNew England Journal of Medicine, 2003